Innovate UK and other partners are to invest up to £10m in an SBRI funded competition to develop biomarker-based Stratified Medicine approaches such as diagnostic tests and analytical algorithms that are capable of stratifying patients for different clinical treatments available in the UK.  

A workshop to discuss the competition is due to take place on Thursday, 2 July 2015 from 10:00 to 15:00 hrs at the Life Sciences Hub Cardiff.

Register here to attend the Cardiff meeting

Innovate UK’s Stratified Medicine Innovation Platform (SMIP), along with its partners in the public and third sector, aims to maximise the potential of stratified medicine in the UK for the benefit of the patients and the economy.  Stratified medicine will provide early and accurate diagnosis and identify the best treatment and disease management for patients. This is of key importance in the treatment of diseases such as cancer, infection, respiratory and inflammatory disease, musculoskeletal disease and dementia.

The adoption of new innovations by healthcare providers has been identified as a challenge to the growth of stratified medicine. Defining the value of the product to the healthcare provider and provision of relevant evidence to support this claim is necessary to enable the adoption of diagnostic testing.  Since inception, SMIP and its partners have created new enabling organisations within the UK, for example the Diagnostic Evidence Cooperatives, Academic Health Science Networks, Precision Medicine Catapult, NICE, Translational partnerships or similar groups in the devolved governments.

Innovate UK and other partners are to invest up to £10m in an SBRI funded competition to develop biomarker-based Stratified Medicine approaches such as diagnostic tests and analytical algorithms that are capable of stratifying patients for different clinical treatments available in the UK.   The aim is to develop and commercialise innovative diagnostic tests by engaging with the organisations within the UK  stratified medicine infrastructure to accelerate the pathway from concept to adoption.

As part of this the KTN intends to run 4 workshops to discuss the competition and allow companies the opportunity to interact with other companies and representatives from relevant parties within the UK infrastructure to build future partnerships.